Global Continuous Glucose Monitoring (CGM) Market Insights, Forecast to 2028

Publisher Name :
Date: 09-Feb-2022
No. of pages: 89
Inquire Before Buying

Continuous Glucose Monitoring (CGM) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Continuous Glucose Monitoring (CGM) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- Transmitters

- Sensors

- Insulin Pumps

Segment by Application

- Hospitals

- Homecare Settings

- Others

By Company

- Pfizer

- Baxter

- Abbott Laboratories

- Medtronic

- Animas

- Novo Nordisk

- Ypsomed

- GlySens

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

Global Continuous Glucose Monitoring (CGM) Market Insights, Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Continuous Glucose Monitoring (CGM) Product Introduction
1.2 Market by Type
1.2.1 Global Continuous Glucose Monitoring (CGM) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Transmitters
1.2.3 Sensors
1.2.4 Insulin Pumps
1.3 Market by Application
1.3.1 Global Continuous Glucose Monitoring (CGM) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Homecare Settings
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Continuous Glucose Monitoring (CGM) Sales Estimates and Forecasts 2017-2028
2.2 Global Continuous Glucose Monitoring (CGM) Revenue Estimates and Forecasts 2017-2028
2.3 Global Continuous Glucose Monitoring (CGM) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Continuous Glucose Monitoring (CGM) Sales by Region
2.4.1 Global Continuous Glucose Monitoring (CGM) Sales by Region (2017-2022)
2.4.2 Global Sales Continuous Glucose Monitoring (CGM) by Region (2023-2028)
2.5 Global Continuous Glucose Monitoring (CGM) Revenue by Region
2.5.1 Global Continuous Glucose Monitoring (CGM) Revenue by Region (2017-2022)
2.5.2 Global Continuous Glucose Monitoring (CGM) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Continuous Glucose Monitoring (CGM) Sales by Manufacturers
3.1.1 Global Top Continuous Glucose Monitoring (CGM) Manufacturers by Sales (2017-2022)
3.1.2 Global Continuous Glucose Monitoring (CGM) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Continuous Glucose Monitoring (CGM) in 2021
3.2 Global Continuous Glucose Monitoring (CGM) Revenue by Manufacturers
3.2.1 Global Continuous Glucose Monitoring (CGM) Revenue by Manufacturers (2017-2022)
3.2.2 Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Continuous Glucose Monitoring (CGM) Revenue in 2021
3.3 Global Continuous Glucose Monitoring (CGM) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Continuous Glucose Monitoring (CGM) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Continuous Glucose Monitoring (CGM) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Continuous Glucose Monitoring (CGM) Sales by Type
4.1.1 Global Continuous Glucose Monitoring (CGM) Historical Sales by Type (2017-2022)
4.1.2 Global Continuous Glucose Monitoring (CGM) Forecasted Sales by Type (2023-2028)
4.1.3 Global Continuous Glucose Monitoring (CGM) Sales Market Share by Type (2017-2028)
4.2 Global Continuous Glucose Monitoring (CGM) Revenue by Type
4.2.1 Global Continuous Glucose Monitoring (CGM) Historical Revenue by Type (2017-2022)
4.2.2 Global Continuous Glucose Monitoring (CGM) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Type (2017-2028)
4.3 Global Continuous Glucose Monitoring (CGM) Price by Type
4.3.1 Global Continuous Glucose Monitoring (CGM) Price by Type (2017-2022)
4.3.2 Global Continuous Glucose Monitoring (CGM) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Continuous Glucose Monitoring (CGM) Sales by Application
5.1.1 Global Continuous Glucose Monitoring (CGM) Historical Sales by Application (2017-2022)
5.1.2 Global Continuous Glucose Monitoring (CGM) Forecasted Sales by Application (2023-2028)
5.1.3 Global Continuous Glucose Monitoring (CGM) Sales Market Share by Application (2017-2028)
5.2 Global Continuous Glucose Monitoring (CGM) Revenue by Application
5.2.1 Global Continuous Glucose Monitoring (CGM) Historical Revenue by Application (2017-2022)
5.2.2 Global Continuous Glucose Monitoring (CGM) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Application (2017-2028)
5.3 Global Continuous Glucose Monitoring (CGM) Price by Application
5.3.1 Global Continuous Glucose Monitoring (CGM) Price by Application (2017-2022)
5.3.2 Global Continuous Glucose Monitoring (CGM) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Continuous Glucose Monitoring (CGM) Market Size by Type
6.1.1 North America Continuous Glucose Monitoring (CGM) Sales by Type (2017-2028)
6.1.2 North America Continuous Glucose Monitoring (CGM) Revenue by Type (2017-2028)
6.2 North America Continuous Glucose Monitoring (CGM) Market Size by Application
6.2.1 North America Continuous Glucose Monitoring (CGM) Sales by Application (2017-2028)
6.2.2 North America Continuous Glucose Monitoring (CGM) Revenue by Application (2017-2028)
6.3 North America Continuous Glucose Monitoring (CGM) Market Size by Country
6.3.1 North America Continuous Glucose Monitoring (CGM) Sales by Country (2017-2028)
6.3.2 North America Continuous Glucose Monitoring (CGM) Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Continuous Glucose Monitoring (CGM) Market Size by Type
7.1.1 Europe Continuous Glucose Monitoring (CGM) Sales by Type (2017-2028)
7.1.2 Europe Continuous Glucose Monitoring (CGM) Revenue by Type (2017-2028)
7.2 Europe Continuous Glucose Monitoring (CGM) Market Size by Application
7.2.1 Europe Continuous Glucose Monitoring (CGM) Sales by Application (2017-2028)
7.2.2 Europe Continuous Glucose Monitoring (CGM) Revenue by Application (2017-2028)
7.3 Europe Continuous Glucose Monitoring (CGM) Market Size by Country
7.3.1 Europe Continuous Glucose Monitoring (CGM) Sales by Country (2017-2028)
7.3.2 Europe Continuous Glucose Monitoring (CGM) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Continuous Glucose Monitoring (CGM) Market Size by Type
8.1.1 Asia Pacific Continuous Glucose Monitoring (CGM) Sales by Type (2017-2028)
8.1.2 Asia Pacific Continuous Glucose Monitoring (CGM) Revenue by Type (2017-2028)
8.2 Asia Pacific Continuous Glucose Monitoring (CGM) Market Size by Application
8.2.1 Asia Pacific Continuous Glucose Monitoring (CGM) Sales by Application (2017-2028)
8.2.2 Asia Pacific Continuous Glucose Monitoring (CGM) Revenue by Application (2017-2028)
8.3 Asia Pacific Continuous Glucose Monitoring (CGM) Market Size by Region
8.3.1 Asia Pacific Continuous Glucose Monitoring (CGM) Sales by Region (2017-2028)
8.3.2 Asia Pacific Continuous Glucose Monitoring (CGM) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Continuous Glucose Monitoring (CGM) Market Size by Type
9.1.1 Latin America Continuous Glucose Monitoring (CGM) Sales by Type (2017-2028)
9.1.2 Latin America Continuous Glucose Monitoring (CGM) Revenue by Type (2017-2028)
9.2 Latin America Continuous Glucose Monitoring (CGM) Market Size by Application
9.2.1 Latin America Continuous Glucose Monitoring (CGM) Sales by Application (2017-2028)
9.2.2 Latin America Continuous Glucose Monitoring (CGM) Revenue by Application (2017-2028)
9.3 Latin America Continuous Glucose Monitoring (CGM) Market Size by Country
9.3.1 Latin America Continuous Glucose Monitoring (CGM) Sales by Country (2017-2028)
9.3.2 Latin America Continuous Glucose Monitoring (CGM) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Continuous Glucose Monitoring (CGM) Market Size by Type
10.1.1 Middle East and Africa Continuous Glucose Monitoring (CGM) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Continuous Glucose Monitoring (CGM) Revenue by Type (2017-2028)
10.2 Middle East and Africa Continuous Glucose Monitoring (CGM) Market Size by Application
10.2.1 Middle East and Africa Continuous Glucose Monitoring (CGM) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Continuous Glucose Monitoring (CGM) Revenue by Application (2017-2028)
10.3 Middle East and Africa Continuous Glucose Monitoring (CGM) Market Size by Country
10.3.1 Middle East and Africa Continuous Glucose Monitoring (CGM) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Continuous Glucose Monitoring (CGM) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Continuous Glucose Monitoring (CGM) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Pfizer Continuous Glucose Monitoring (CGM) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Baxter
11.2.1 Baxter Corporation Information
11.2.2 Baxter Overview
11.2.3 Baxter Continuous Glucose Monitoring (CGM) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Baxter Continuous Glucose Monitoring (CGM) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Baxter Recent Developments
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Corporation Information
11.3.2 Abbott Laboratories Overview
11.3.3 Abbott Laboratories Continuous Glucose Monitoring (CGM) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Abbott Laboratories Continuous Glucose Monitoring (CGM) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Abbott Laboratories Recent Developments
11.4 Medtronic
11.4.1 Medtronic Corporation Information
11.4.2 Medtronic Overview
11.4.3 Medtronic Continuous Glucose Monitoring (CGM) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Medtronic Continuous Glucose Monitoring (CGM) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Medtronic Recent Developments
11.5 Animas
11.5.1 Animas Corporation Information
11.5.2 Animas Overview
11.5.3 Animas Continuous Glucose Monitoring (CGM) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Animas Continuous Glucose Monitoring (CGM) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Animas Recent Developments
11.6 Novo Nordisk
11.6.1 Novo Nordisk Corporation Information
11.6.2 Novo Nordisk Overview
11.6.3 Novo Nordisk Continuous Glucose Monitoring (CGM) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Novo Nordisk Continuous Glucose Monitoring (CGM) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Novo Nordisk Recent Developments
11.7 Ypsomed
11.7.1 Ypsomed Corporation Information
11.7.2 Ypsomed Overview
11.7.3 Ypsomed Continuous Glucose Monitoring (CGM) Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Ypsomed Continuous Glucose Monitoring (CGM) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Ypsomed Recent Developments
11.8 GlySens
11.8.1 GlySens Corporation Information
11.8.2 GlySens Overview
11.8.3 GlySens Continuous Glucose Monitoring (CGM) Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 GlySens Continuous Glucose Monitoring (CGM) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 GlySens Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Continuous Glucose Monitoring (CGM) Industry Chain Analysis
12.2 Continuous Glucose Monitoring (CGM) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Continuous Glucose Monitoring (CGM) Production Mode & Process
12.4 Continuous Glucose Monitoring (CGM) Sales and Marketing
12.4.1 Continuous Glucose Monitoring (CGM) Sales Channels
12.4.2 Continuous Glucose Monitoring (CGM) Distributors
12.5 Continuous Glucose Monitoring (CGM) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Continuous Glucose Monitoring (CGM) Industry Trends
13.2 Continuous Glucose Monitoring (CGM) Market Drivers
13.3 Continuous Glucose Monitoring (CGM) Market Challenges
13.4 Continuous Glucose Monitoring (CGM) Market Restraints
14 Key Findings in The Global Continuous Glucose Monitoring (CGM) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Continuous Glucose Monitoring (CGM) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Transmitters
Table 3. Major Manufacturers of Sensors
Table 4. Major Manufacturers of Insulin Pumps
Table 5. Global Continuous Glucose Monitoring (CGM) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Continuous Glucose Monitoring (CGM) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Continuous Glucose Monitoring (CGM) Sales by Region (2017-2022) & (K Units)
Table 8. Global Continuous Glucose Monitoring (CGM) Sales Market Share by Region (2017-2022)
Table 9. Global Continuous Glucose Monitoring (CGM) Sales by Region (2023-2028) & (K Units)
Table 10. Global Continuous Glucose Monitoring (CGM) Sales Market Share by Region (2023-2028)
Table 11. Global Continuous Glucose Monitoring (CGM) Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Region (2017-2022)
Table 13. Global Continuous Glucose Monitoring (CGM) Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Region (2023-2028)
Table 15. Global Continuous Glucose Monitoring (CGM) Sales by Manufacturers (2017-2022) & (K Units)
Table 16. Global Continuous Glucose Monitoring (CGM) Sales Share by Manufacturers (2017-2022)
Table 17. Global Continuous Glucose Monitoring (CGM) Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Continuous Glucose Monitoring (CGM) Revenue Share by Manufacturers (2017-2022)
Table 19. Continuous Glucose Monitoring (CGM) Price by Manufacturers (2017-2022) &(USD/Unit)
Table 20. Global Continuous Glucose Monitoring (CGM) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Continuous Glucose Monitoring (CGM) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Continuous Glucose Monitoring (CGM) as of 2021)
Table 22. Continuous Glucose Monitoring (CGM) Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Continuous Glucose Monitoring (CGM) Product Offered
Table 24. Date of Manufacturers Enter into Continuous Glucose Monitoring (CGM) Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Continuous Glucose Monitoring (CGM) Sales by Type (2017-2022) & (K Units)
Table 27. Global Continuous Glucose Monitoring (CGM) Sales by Type (2023-2028) & (K Units)
Table 28. Global Continuous Glucose Monitoring (CGM) Sales Share by Type (2017-2022)
Table 29. Global Continuous Glucose Monitoring (CGM) Sales Share by Type (2023-2028)
Table 30. Global Continuous Glucose Monitoring (CGM) Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Continuous Glucose Monitoring (CGM) Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Continuous Glucose Monitoring (CGM) Revenue Share by Type (2017-2022)
Table 33. Global Continuous Glucose Monitoring (CGM) Revenue Share by Type (2023-2028)
Table 34. Continuous Glucose Monitoring (CGM) Price by Type (2017-2022) & (USD/Unit)
Table 35. Global Continuous Glucose Monitoring (CGM) Price Forecast by Type (2023-2028) & (USD/Unit)
Table 36. Global Continuous Glucose Monitoring (CGM) Sales by Application (2017-2022) & (K Units)
Table 37. Global Continuous Glucose Monitoring (CGM) Sales by Application (2023-2028) & (K Units)
Table 38. Global Continuous Glucose Monitoring (CGM) Sales Share by Application (2017-2022)
Table 39. Global Continuous Glucose Monitoring (CGM) Sales Share by Application (2023-2028)
Table 40. Global Continuous Glucose Monitoring (CGM) Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Continuous Glucose Monitoring (CGM) Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Continuous Glucose Monitoring (CGM) Revenue Share by Application (2017-2022)
Table 43. Global Continuous Glucose Monitoring (CGM) Revenue Share by Application (2023-2028)
Table 44. Continuous Glucose Monitoring (CGM) Price by Application (2017-2022) & (USD/Unit)
Table 45. Global Continuous Glucose Monitoring (CGM) Price Forecast by Application (2023-2028) & (USD/Unit)
Table 46. North America Continuous Glucose Monitoring (CGM) Sales by Type (2017-2022) & (K Units)
Table 47. North America Continuous Glucose Monitoring (CGM) Sales by Type (2023-2028) & (K Units)
Table 48. North America Continuous Glucose Monitoring (CGM) Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Continuous Glucose Monitoring (CGM) Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Continuous Glucose Monitoring (CGM) Sales by Application (2017-2022) & (K Units)
Table 51. North America Continuous Glucose Monitoring (CGM) Sales by Application (2023-2028) & (K Units)
Table 52. North America Continuous Glucose Monitoring (CGM) Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Continuous Glucose Monitoring (CGM) Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Continuous Glucose Monitoring (CGM) Sales by Country (2017-2022) & (K Units)
Table 55. North America Continuous Glucose Monitoring (CGM) Sales by Country (2023-2028) & (K Units)
Table 56. North America Continuous Glucose Monitoring (CGM) Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Continuous Glucose Monitoring (CGM) Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Continuous Glucose Monitoring (CGM) Sales by Type (2017-2022) & (K Units)
Table 59. Europe Continuous Glucose Monitoring (CGM) Sales by Type (2023-2028) & (K Units)
Table 60. Europe Continuous Glucose Monitoring (CGM) Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Continuous Glucose Monitoring (CGM) Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Continuous Glucose Monitoring (CGM) Sales by Application (2017-2022) & (K Units)
Table 63. Europe Continuous Glucose Monitoring (CGM) Sales by Application (2023-2028) & (K Units)
Table 64. Europe Continuous Glucose Monitoring (CGM) Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Continuous Glucose Monitoring (CGM) Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Continuous Glucose Monitoring (CGM) Sales by Country (2017-2022) & (K Units)
Table 67. Europe Continuous Glucose Monitoring (CGM) Sales by Country (2023-2028) & (K Units)
Table 68. Europe Continuous Glucose Monitoring (CGM) Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Continuous Glucose Monitoring (CGM) Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Continuous Glucose Monitoring (CGM) Sales by Type (2017-2022) & (K Units)
Table 71. Asia Pacific Continuous Glucose Monitoring (CGM) Sales by Type (2023-2028) & (K Units)
Table 72. Asia Pacific Continuous Glucose Monitoring (CGM) Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Continuous Glucose Monitoring (CGM) Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Continuous Glucose Monitoring (CGM) Sales by Application (2017-2022) & (K Units)
Table 75. Asia Pacific Continuous Glucose Monitoring (CGM) Sales by Application (2023-2028) & (K Units)
Table 76. Asia Pacific Continuous Glucose Monitoring (CGM) Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Continuous Glucose Monitoring (CGM) Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Continuous Glucose Monitoring (CGM) Sales by Region (2017-2022) & (K Units)
Table 79. Asia Pacific Continuous Glucose Monitoring (CGM) Sales by Region (2023-2028) & (K Units)
Table 80. Asia Pacific Continuous Glucose Monitoring (CGM) Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Continuous Glucose Monitoring (CGM) Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Continuous Glucose Monitoring (CGM) Sales by Type (2017-2022) & (K Units)
Table 83. Latin America Continuous Glucose Monitoring (CGM) Sales by Type (2023-2028) & (K Units)
Table 84. Latin America Continuous Glucose Monitoring (CGM) Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Continuous Glucose Monitoring (CGM) Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Continuous Glucose Monitoring (CGM) Sales by Application (2017-2022) & (K Units)
Table 87. Latin America Continuous Glucose Monitoring (CGM) Sales by Application (2023-2028) & (K Units)
Table 88. Latin America Continuous Glucose Monitoring (CGM) Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Continuous Glucose Monitoring (CGM) Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Continuous Glucose Monitoring (CGM) Sales by Country (2017-2022) & (K Units)
Table 91. Latin America Continuous Glucose Monitoring (CGM) Sales by Country (2023-2028) & (K Units)
Table 92. Latin America Continuous Glucose Monitoring (CGM) Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Continuous Glucose Monitoring (CGM) Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Continuous Glucose Monitoring (CGM) Sales by Type (2017-2022) & (K Units)
Table 95. Middle East and Africa Continuous Glucose Monitoring (CGM) Sales by Type (2023-2028) & (K Units)
Table 96. Middle East and Africa Continuous Glucose Monitoring (CGM) Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Continuous Glucose Monitoring (CGM) Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Continuous Glucose Monitoring (CGM) Sales by Application (2017-2022) & (K Units)
Table 99. Middle East and Africa Continuous Glucose Monitoring (CGM) Sales by Application (2023-2028) & (K Units)
Table 100. Middle East and Africa Continuous Glucose Monitoring (CGM) Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Continuous Glucose Monitoring (CGM) Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Continuous Glucose Monitoring (CGM) Sales by Country (2017-2022) & (K Units)
Table 103. Middle East and Africa Continuous Glucose Monitoring (CGM) Sales by Country (2023-2028) & (K Units)
Table 104. Middle East and Africa Continuous Glucose Monitoring (CGM) Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Continuous Glucose Monitoring (CGM) Revenue by Country (2023-2028) & (US$ Million)
Table 106. Pfizer Corporation Information
Table 107. Pfizer Description and Major Businesses
Table 108. Pfizer Continuous Glucose Monitoring (CGM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 109. Pfizer Continuous Glucose Monitoring (CGM) Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Pfizer Recent Developments
Table 111. Baxter Corporation Information
Table 112. Baxter Description and Major Businesses
Table 113. Baxter Continuous Glucose Monitoring (CGM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 114. Baxter Continuous Glucose Monitoring (CGM) Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Baxter Recent Developments
Table 116. Abbott Laboratories Corporation Information
Table 117. Abbott Laboratories Description and Major Businesses
Table 118. Abbott Laboratories Continuous Glucose Monitoring (CGM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 119. Abbott Laboratories Continuous Glucose Monitoring (CGM) Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Abbott Laboratories Recent Developments
Table 121. Medtronic Corporation Information
Table 122. Medtronic Description and Major Businesses
Table 123. Medtronic Continuous Glucose Monitoring (CGM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 124. Medtronic Continuous Glucose Monitoring (CGM) Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Medtronic Recent Developments
Table 126. Animas Corporation Information
Table 127. Animas Description and Major Businesses
Table 128. Animas Continuous Glucose Monitoring (CGM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 129. Animas Continuous Glucose Monitoring (CGM) Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Animas Recent Developments
Table 131. Novo Nordisk Corporation Information
Table 132. Novo Nordisk Description and Major Businesses
Table 133. Novo Nordisk Continuous Glucose Monitoring (CGM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 134. Novo Nordisk Continuous Glucose Monitoring (CGM) Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Novo Nordisk Recent Developments
Table 136. Ypsomed Corporation Information
Table 137. Ypsomed Description and Major Businesses
Table 138. Ypsomed Continuous Glucose Monitoring (CGM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 139. Ypsomed Continuous Glucose Monitoring (CGM) Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Ypsomed Recent Developments
Table 141. GlySens Corporation Information
Table 142. GlySens Description and Major Businesses
Table 143. GlySens Continuous Glucose Monitoring (CGM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 144. GlySens Continuous Glucose Monitoring (CGM) Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. GlySens Recent Developments
Table 146. Key Raw Materials Lists
Table 147. Raw Materials Key Suppliers Lists
Table 148. Continuous Glucose Monitoring (CGM) Distributors List
Table 149. Continuous Glucose Monitoring (CGM) Customers List
Table 150. Continuous Glucose Monitoring (CGM) Market Trends
Table 151. Continuous Glucose Monitoring (CGM) Market Drivers
Table 152. Continuous Glucose Monitoring (CGM) Market Challenges
Table 153. Continuous Glucose Monitoring (CGM) Market Restraints
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Continuous Glucose Monitoring (CGM) Product Picture
Figure 3. Global Continuous Glucose Monitoring (CGM) Market Share by Type in 2021 & 2028
Figure 3. Transmitters Product Picture
Figure 4. Sensors Product Picture
Figure 5. Insulin Pumps Product Picture
Figure 6. Global Continuous Glucose Monitoring (CGM) Market Share by Application in 2021 & 2028
Figure 7. Hospitals
Figure 8. Homecare Settings
Figure 9. Others
Figure 10. Continuous Glucose Monitoring (CGM) Report Years Considered
Figure 11. Global Continuous Glucose Monitoring (CGM) Sales 2017-2028 (K Units)
Figure 12. Global Continuous Glucose Monitoring (CGM) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Continuous Glucose Monitoring (CGM) Revenue 2017-2028 (US$ Million)
Figure 14. Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Continuous Glucose Monitoring (CGM) Sales Market Share by Region (2017-2022)
Figure 16. Global Continuous Glucose Monitoring (CGM) Sales Market Share by Region (2023-2028)
Figure 17. North America Continuous Glucose Monitoring (CGM) Sales YoY (2017-2028) & (K Units)
Figure 18. North America Continuous Glucose Monitoring (CGM) Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Continuous Glucose Monitoring (CGM) Sales YoY (2017-2028) & (K Units)
Figure 20. Europe Continuous Glucose Monitoring (CGM) Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Continuous Glucose Monitoring (CGM) Sales YoY (2017-2028) & (K Units)
Figure 22. Asia-Pacific Continuous Glucose Monitoring (CGM) Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Continuous Glucose Monitoring (CGM) Sales YoY (2017-2028) & (K Units)
Figure 24. Latin America Continuous Glucose Monitoring (CGM) Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Continuous Glucose Monitoring (CGM) Sales YoY (2017-2028) & (K Units)
Figure 26. Middle East & Africa Continuous Glucose Monitoring (CGM) Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Continuous Glucose Monitoring (CGM) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Continuous Glucose Monitoring (CGM) in the World: Market Share by Continuous Glucose Monitoring (CGM) Revenue in 2021
Figure 29. Global Continuous Glucose Monitoring (CGM) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Continuous Glucose Monitoring (CGM) Sales Market Share by Type (2017-2028)
Figure 31. Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Type (2017-2028)
Figure 32. Global Continuous Glucose Monitoring (CGM) Sales Market Share by Application (2017-2028)
Figure 33. Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Application (2017-2028)
Figure 34. North America Continuous Glucose Monitoring (CGM) Sales Market Share by Type (2017-2028)
Figure 35. North America Continuous Glucose Monitoring (CGM) Revenue Market Share by Type (2017-2028)
Figure 36. North America Continuous Glucose Monitoring (CGM) Sales Market Share by Application (2017-2028)
Figure 37. North America Continuous Glucose Monitoring (CGM) Revenue Market Share by Application (2017-2028)
Figure 38. North America Continuous Glucose Monitoring (CGM) Sales Share by Country (2017-2028)
Figure 39. North America Continuous Glucose Monitoring (CGM) Revenue Share by Country (2017-2028)
Figure 40. U.S. Continuous Glucose Monitoring (CGM) Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Continuous
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs